Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets.
- DOI
- 10.1200/jgo.19.00341
- Published
- 2020-03-01
- Container
- JCO Glob Oncol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1200/jgo.19.00341,
title = {Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets.},
author = {Patel A and Tannock IF and Srivastava P and Biswas B and Gupta VG and Batra A and Bhethanabhotla S and Pramanik R and Mahindru S and Tilak T and Das CK and Mehta P.},
year = {2020},
journal = {JCO Glob Oncol},
doi = {10.1200/jgo.19.00341},
url = {https://doi.org/10.1200/jgo.19.00341}
}RIS
TY - JOUR TI - Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets. AU - Patel A AU - Tannock IF AU - Srivastava P AU - Biswas B AU - Gupta VG AU - Batra A AU - Bhethanabhotla S AU - Pramanik R AU - Mahindru S AU - Tilak T AU - Das CK AU - Mehta P. PY - 2020 JO - JCO Glob Oncol DO - 10.1200/jgo.19.00341 UR - https://doi.org/10.1200/jgo.19.00341 ER -
APA
A, P., IF, T., P, S., B, B., VG, G., A, B., S, B., R, P., S, M., T, T., CK, D., & P., M. (2020). Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets.. JCO Glob Oncol. https://doi.org/10.1200/jgo.19.00341
Source records
- europe-pmc · retrieved 2026-09-25T13:13:53.191Z
- doaj · retrieved 2026-09-25T13:13:53.216Z